Stryker Corp. (SYK) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Stryker’s revenue went from $11.3B in fiscal 2016 to $25.1B in fiscal 2025, growth of about 9.3% a year.
Net income in fiscal 2025 was $3.2B, a net margin of 12.9%; the best year in this period was 2018 with $3.6B.
Over the twelve months to September 30, 2026, revenue was $26.3B and net income $3.6B.
Free cash flow was $4.3B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 2% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.3B | $25.1B | $22.6B | $20.5B | $18.4B | $17.1B | $14.4B | $14.9B | $13.6B | $12.4B | $11.3B |
| Gross profit | $17.2B | $16.1B | $14.4B | $13.1B | $11.6B | $11.0B | $9.1B | $9.7B | $8.9B | $8.2B | $7.5B |
| Operating income | $5.4B | $4.9B | $3.7B | $3.9B | $2.8B | $2.6B | $2.2B | $2.7B | $2.5B | $2.3B | $2.2B |
| Net income | $3.6B | $3.2B | $3.0B | $3.2B | $2.4B | $2.0B | $1.6B | $2.1B | $3.6B | $1.0B | $1.6B |
| EPS (diluted) | $9.39 | $8.40 | $7.76 | $8.25 | $6.17 | $5.21 | $4.20 | $5.48 | $9.34 | $2.68 | $4.35 |
| R&D | $1.7B | $1.6B | $1.5B | $1.4B | $1.5B | $1.2B | $984M | $971M | $862M | $787M | $715M |
| Revenue growth | — | +11.2% | +10.2% | +11.1% | +7.8% | +19.2% | −3.6% | +9.4% | +9.3% | +9.9% | +13.9% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.4B | $5.0B | $4.2B | $3.7B | $2.6B | $3.3B | $3.3B | $2.2B | $2.6B | $1.6B | $1.9B |
| Capital spending | -$873M | -$761M | -$755M | -$575M | -$588M | -$525M | -$487M | -$649M | -$572M | -$598M | -$490M |
| Free cash flow | $4.6B | $4.3B | $3.5B | $3.1B | $2.0B | $2.7B | $2.8B | $1.5B | $2.0B | $961M | $1.4B |
| Dividends paid | $1.3B | $1.3B | $1.2B | $1.1B | $1.1B | $950M | $863M | $778M | $703M | $636M | $568M |
| Buybacks | — | — | — | — | — | $0 | $0 | $307M | $300M | $230M | $13M |
| Stock-based pay | $256M | $243M | $229M | $205M | $168M | $171M | $142M | $127M | $119M | $113M | $97M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $4.1B | $3.7B | $3.1B | $1.9B | $3.0B | $3.0B | $4.4B | $3.6B | $2.5B | $3.3B |
| Debt | — | $16.4B | $14.1B | $13.5B | $13.5B | $12.9B | $14.4B | $11.5B | $9.9B | $7.2B | $6.9B |
| Equity | — | $22.4B | $20.6B | $18.6B | $16.6B | $14.9B | $13.1B | $12.8B | $11.7B | $10.0B | $9.6B |
| Total assets | — | $47.8B | $43.0B | $39.9B | $36.9B | $34.6B | $34.3B | $30.2B | $27.2B | $22.2B | $20.4B |
| Shares (diluted) | 385M | 386M | 386M | 384M | 382M | 382M | 380M | 380M | 380M | 380M | 378M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 65.3% | 64.0% | 63.9% | 63.7% | 62.8% | 64.1% | 63.1% | 65.1% | 65.7% | 65.7% | 66.3% |
| Operating margin | 20.7% | 19.5% | 16.3% | 19.0% | 15.4% | 15.1% | 15.5% | 18.2% | 18.6% | 18.5% | 19.2% |
| Net margin | 13.8% | 12.9% | 13.2% | 15.4% | 12.8% | 11.7% | 11.1% | 14.0% | 26.1% | 8.2% | 14.5% |
| FCF margin | 17.4% | 17.1% | 15.4% | 15.3% | 11.0% | 16.0% | 19.4% | 10.4% | 15.0% | 7.7% | 12.6% |
| ROIC | — | 9.1% | 9.1% | 10.4% | 8.3% | 8.1% | 6.6% | 9.1% | 9.3% | 10.6% | 11.3% |
| ROE | — | 14.5% | 14.5% | 17.0% | 14.2% | 13.4% | 12.2% | 16.3% | 30.3% | 10.2% | 17.2% |
Frequently asked questions
What is Stryker’s annual revenue?
$25.1B in fiscal 2025 and $26.3B over the twelve months to September 30, 2026.
How much profit does Stryker make?
Net income was $3.2B in fiscal 2025 (net margin 12.9%).
Is Stryker’s revenue growing?
Yes: revenue rose 11.2% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.